Cannabis operators heading into 2027 are navigating three collision points at once: federal rescheduling that remains unresolved, a looming federal crackdown on intoxicating hemp products, and a
Acting Attorney General Todd Blanche signed an order last week that moves state-licensed medical cannabis products and prospective FDA-approved cannabis products from Schedule I to Schedule III - a
The Trump administration moved on Thursday to reclassify medical marijuana from Schedule I to Schedule III under the Controlled Substances Act - and within hours, the Treasury Department and IRS